Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7443 p298
17 March 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
DoH reports
• “The way ahead: the local challenge, the NSF four years on
• Insulin Pumps Working Group’s report


Diabetes progress report ignores pharmacy's role

Report: The way ahead: the local challenge, the NSF four years on

Report cites examples of good practice

Improvements in services for people with diabetes continue to be seen across the NHS but there are still gaps that need to be filled, a report published by the Department of Health last week reveals. The report describes progress being made since the Diabetes National Service Framework was launched four years ago. But, despite including 22 case reports of good practice across the NHS, it does not mention pharmacy.

Paul Gimson, lead pharmacist for long-term care at the Royal Pharmaceutical Society, said: “It is disappointing that the report does not mention the work that pharmacists are doing in this area, and the potential of pharmacy to address this problem.”

He added that the Government strategy “Choosing health through pharmacy” and the National Diabetes Support Team have already recognised pharmacy as a vital network for supporting public health in these areas. “The Society urges commissioners to consider the potential benefit of pharmacy when designing services,” he said.

Shailen Rao, an independent consultant and chairman of the Primary Care Pharmacists’ Association, has had extensive experience of redesigning diabetes services. “It is heartening to see that good progress is being made in the management of diabetes around the country. It is disappointing that the role of pharmacists has not been given the recognition it deserves. The combination of the new pharmacy contract and practice-based commissioning provides a golden opportunity to engage pharmacists, who are ideally placed to help patients make better use of their medicines — a well documented problem for people with diabetes and a major area of investment by the NHS,” he said.

The DoH report says that the commissioning process must be grounded in a comprehensive needs assessment. It also indicates that needs are likely to be met only through innovative solutions from independent providers.

Health minister Rosie Winterton said: “As more people are diagnosed with diabetes the NHS must step up to the challenge of continuing to provide high quality services that are convenient for patients. The NSF progress report demonstrates that excellent work is already under way and I would urge PCTs to look at how they can best provide services for people with diabetes in their local area.”

A second report published by the DoH last week considers the use of insulin pumps within the NHS. It follows guidance from the National Institute for Clinical Excellence published in 2003, and recommends that pump therapy be included as part of a comprehensive service for type 1 diabetes.

Back to Top


©The Pharmaceutical Journal